Literature DB >> 26362801

Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.

Maja Travar1,2, Miroslav Petkovic3, Antonija Verhaz4.   

Abstract

Interferons (IFNs) are cytokines released by host cells in response to the presence of pathogens or tumor cells. The aim of this review was to present the previously known and new findings about the role of interferons type I and II, and recently discovered type III in Mycobacterium tuberculosis (M. tuberculosis) infection control. Infection of various cell types with M. tuberculosis induce both IFN-α and IFN-β synthesis. The majority of the studies support the findings that IFN type I actually promotes infection with M. tuberculosis. It has been well establish that IFN-γ has protective function against M. tuberculosis and the other mycobacteria and that the primary source of this cytokine are CD4(+) and CD8(+) T cells. Recently, it has been shown that also the innate lymphocytes, γδ T cells, natural killer (NK) T cells, and NK cells can also be the source of IFN-γ in response to mycobacterial infection. Several studies have shown that CD4(+) T cells protect mice against M. tuberculosis independently of IFN-γ. The balance between IFN-γ and different cytokines such as IL-10 and other Th2 cell cytokines is likely to influence disease outcome. Type I IFN appears to be detrimental through at least three separate, but overlapping, type I IFN-mediated mechanisms: induction of excessive apoptosis, specific suppression of Th1 and IFN-γ responses, and dampening of the immune response by strong IL-10 induction. Recently it has been found that M. tuberculosis infection in A549 lung epithelial cells stimulate up-regulation of IFN-λ genes in vitro. IFN-λs also have a role in modulation of Th1/Th2 response. IFN-λs are not essential for M. tuberculosis infection control, but can give some contribution in immune response to this pathogen.

Entities:  

Keywords:  Interferon; Interferon lambda; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26362801     DOI: 10.1007/s00005-015-0365-7

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  11 in total

Review 1.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

Review 2.  Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.

Authors:  Dongfang Liu; Shuo Tian; Kai Zhang; Wei Xiong; Ndongala Michel Lubaki; Zhiying Chen; Weidong Han
Journal:  Protein Cell       Date:  2017-05-09       Impact factor: 14.870

3.  Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis.

Authors:  Stefania Parlato; Teresa Chiacchio; Debora Salerno; Linda Petrone; Luciano Castiello; Giulia Romagnoli; Irene Canini; Delia Goletti; Lucia Gabriele
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

Review 4.  Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation.

Authors:  Eik Hoffmann; Arnaud Machelart; Ok-Ryul Song; Priscille Brodin
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

Review 5.  Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.

Authors:  Kai Ling Chin; Fadhilah Zulkipli Anis; Maria E Sarmiento; Mohd Nor Norazmi; Armando Acosta
Journal:  J Immunol Res       Date:  2017-06-20       Impact factor: 4.818

6.  Different Signaling Pathways Define Different Interferon-Stimulated Gene Expression during Mycobacteria Infection in Macrophages.

Authors:  Xinying Zhou; Jiahui Yang; Zelin Zhang; Lijie Zhang; Bo Zhu; Linmiao Lie; Yubin Huang; Rui Ma; Chaoying Zhou; Shengfeng Hu; Qian Wen; Li Ma
Journal:  Int J Mol Sci       Date:  2019-02-03       Impact factor: 5.923

Review 7.  How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication.

Authors:  Wolfgang Eisenreich; Thomas Rudel; Jürgen Heesemann; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2019-03-04       Impact factor: 5.293

Review 8.  Infection resisters: targets of new research for uncovering natural protective immunity against Mycobacterium tuberculosis.

Authors:  Vaishnavi Kaipilyawar; Padmini Salgame
Journal:  F1000Res       Date:  2019-09-27

9.  Enhanced Proinflammatory Cytokine Production and Immunometabolic Impairment of NK Cells Exposed to Mycobacterium tuberculosis and Cigarette Smoke.

Authors:  Yafei Rao; Xiaoyan Gai; Yanqing Le; Jing Xiong; Yujia Liu; Xueyang Zhang; Jundong Wang; Wenli Cao; Yongchang Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

10.  A comprehensive transcriptomic analysis of alternate interferon signaling pathways in peripheral blood mononuclear cells in rheumatoid arthritis.

Authors:  Liang Han; Shenghao Tu; Pan Shen; Jiahui Yan; Yao Huang; Xin Ba; Tingting Li; Weiji Lin; Huihui Li; Kun Yu; Jing Guo; Ying Huang; Kai Qin; Yu Wang; Zhe Chen
Journal:  Aging (Albany NY)       Date:  2021-08-25       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.